GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

Journal of Clinical Epidemiology

Volumn 66, Issue 2, 2013, Pages 140-150

  Brunetti, Massimo ^a   Shemilt, Ian ^b   Pregno, Silvia ^c   Vale, Luke ^d   Oxman, Andrew D ^e   Lord, Joanne ^f   Sisk, Jane ^g   Ruiz, Francis ^h   Hill, Suzanne ⁱ   Guyatt, Gordon H ^j   Jaeschke, Roman ^j   Helfand, Mark ^k   Harbour, Robin ^l   Davoli, Marina ^m   Amato, Laura ^m   Liberati, Alessandro ^c   Schünemann, Holger J ^j  

^a AUSL Modena   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^f BRUNEL UNIVERSITY   (United Kingdom)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j MCMASTER UNIVERSITY   (Canada)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l Scottish Intercollegiate Guidelines Network   (United Kingdom)

^m DEPARTMENT OF EPIDEMIOLOGY   (Italy)

more..

Author keywords

Costs; Economic evaluations; GRADE; Health technology assessment; Quality of evidence; Risk of bias

Indexed keywords

ARTICLE; DECISION MAKING; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH CARE RATIONING; HEALTH RESOURCES; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 84871275040     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2012.04.012     Document Type: Article

References (36)

1. M. Drummond, M. Sculpher, G. Torrance, B. O'Brien, and G. Stoddart Methods for the economic evaluation of health care programmes 3rd ed. 2005 Oxford University Press Oxford, UK
2. M. Sculpher, F. Pang, and A. Manca Generalisability in economic evaluation studies in healthcare: a review and case studies Health Technol Assess 8 2004 1 192
3. M.J. Buxton, M.F. Drummond, B.A. van Hout, R.L. Prince, T.A. Sheldon, and T. Szucs Modelling in economic evaluation: an unavoidable fact of life Health Econ 6 3 1997 217 227
4. J. Hjelmgren, F. Berggren, and F. Andersson Health economic guidelines - similarities, differences and some implications Value Health 4 3 2001 225 250
5. G.H. Guyatt, A.D. Oxman, R. Kunz, R. Jaeschke, M. Helfand, and A. Liberati Grading recommendations: incorporating considerations of resources use BMJ 336 2008 1170 1173
6. Impact-RSV Study Group Palivizumab, a humanized respiratory syncitial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants Pediatrics 102 1998 531 537
7. M.F. Drummond, and T.O. Jefferson Guidelines for authors and peer reviewers of economic submissions to the BMJ BMJ 313 1996 275 283
8. I. Shemilt, J. Thomas, and M. Morciano A web-based tool for adjusting costs to a specific target currency and price year Evid Policy 6 1 2010 51 59
9. R.P. Mattick, J. Kimber, C. Breen, and M. Davoli Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence Cochrane Database Syst Rev 2 2008 CD002207
10. A. Harris, E. Gospodarevskaya, and A. Ritter A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting Pharmacoeconomics 23 1 2005 77 91
11. C.M. Doran, M. Shanahan, R.P. Mattick, R. Ali, J. White, and J. Bell Buprenorphine versus methadone maintenance: a cost-effectiveness analysis Drug Alcohol Depend 71 2003 295 302
12. G.H. Guyatt, A.D. Oxman, and R. Kunz GRADE guidelines: 7. rating the quality of evidence - inconsistency J Clin Epidemiol 64 2011 1294 1302
13. I. Shemilt, M. Mugford, S. Byford, M. Drummond, E. Eisenstein, and M. Knapp Chapter 15: incorporating economics evidence J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions 2008 John Wiley & Sons Chichester, UK 449 479
14. R. Anderson Systematic reviews of economic evaluations: utility or futility? Health Econ 19 2010 350 364
15. M. Drummond Chapter 15: evidence-based decisions and economics: an agenda for research I. Shemilt, M. Mugford, L. Vale, K. Marsh, C. Donaldson, Evidence-based decisions and economics: health care, social welfare, education and criminal justice 2010 Wiley-Blackwell Oxford, UK 179 185
16. B.R. Luce, W.G. Manning, J.E. Siegel, and J. Lipscomb Estimating costs in cost-effectiveness analysis M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, Cost-effectiveness in health and medicine 1996 Oxford University Press New York, NY 176 185
17. S. Evers, M. Goossens, H. de Vet, M. van Tulder, and A. Ament Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria Int J Technol Assess Health Care 21 2005 240 245
18. G.H. Guyatt, A.D. Oxman, R. Kunz GRADE Working Group GRADE: what is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998
19. H. Balshem, M. Helfand, H.J. Schunemann, A.D. Oxman, R. Kunz, and J. Brozek GRADE guidelines: 3 rating the quality of evidence - introduction J Clin Epidemiol 64 2011 401 406
20. G.H. Guyatt, A.D. Oxman, R. Kunz, J. Woodcock, J. Brozek, and M. Helfand GRADE guidelines 8: rating the quality of evidence - indirectness J Clin Epidemiol 64 2011 1303 1310
21. G.H. Guyatt, A.D. Oxman, S. Sultan, P. Glasziou, E.A. Akl, and P. Alonso-Coello GRADE guidelines: 9. rating up the quality of evidence J Clin Epidemiol 64 2011 1311 1316
22. D. Coyle, and K.M. Lee The problem of protocol driven costs in pharmacoeconomic analysis Pharmacoeconomics 14 4 1998 357 363
23. G.H. Guyatt, A.D. Oxman, G. Vist, R. Kunz, J. Brozek, and P. Alonso-Coello GRADE guidelines: 4. rating the quality of evidence - risk of bias J Clin Epidemiol 64 2011 407 415
24. J. Coast, S.H. Richards, T.J. Peters, D.J. Gunnell, M.A. Darlow, and J. Pounsford Hospital at home or acute hospital care? A cost minimization analysis BMJ 316 1998 1802 1806
25. S. Petrou, L. Murray, P. Cooper, and L.L. Davidson The accuracy of self-reported healthcare resource utilization in health economic studies Int J Technol Assess Health Care 18 2002 705 710
26. S.L. Hughes, J. Cummings, F. Weaver, L. Manheim, B. Braun, and K. Conrad A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill Health Serv Res 26 1992 801 817
27. J. Simon, A. Gray, L. Duley Magpie Trial Collaborative Group Cost-effectiveness of prophylactic 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial BJOG 113 2006 144 151
28. R. Baltussen, A. Ament, and R. Leidl Making cost assessment based on RCTs more useful to decision makers Health Policy 37 1996 163 183
29. I. Shemilt, M. Mugford, L. Vale, K. Marsh, and C. Donaldson Evidence-based decisions and economics 2010 Wiley-Blackwell Oxford, UK
30. A. Briggs Economic evaluation and clinical trials: size matters BMJ 321 2000 132 133
31. J.A. Doshi, A.G. Henry, and D. Polsky Analyses of cost data in economic evaluations conducted alongside randomized controlled data Value Health 9 5 2006 334 340
32. A. Briggs, and A.M. Gray Handling uncertainty when performing economic evaluation of healthcare interventions Health Technol Assess 3 1999 1 134
33. G.H. Guyatt, A.D. Oxman, and V. Montori GRADE guidelines 5: rating the quality of evidence - publication bias J Clin Epidemiol 64 2011 1277 1282
34. N. Cooper, D. Coyle, K. Abrams, M. Mugford, and A. Sutton Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997 J Health Serv Res Policy 10 2005 245 250
35. A.G. Marson, A.M. Al-Kharusi, M. Alwaidh, R. Appleton, G.A. Baker, and D.W. Chadwick The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1000 1015
36. J. Glanville, and S. Paisley Chapter 7: searching for evidence for cost-effectiveness decisions I. Shemilt, M. Mugford, L. Vale, K. Marsh, C. Donaldson, Evidence-based decisions and economics 2010 Wiley-Blackwell Oxford, UK